Interobserver variability in the interpretation of tumor cell necrosis in uterine leiomyosarcoma

American Journal of Surgical Pathology

Volumn 37, Issue 5, 2013, Pages 650-658

  Lim, Diana ^a   Alvarez, Teresa ^b   Nucci, Marisa R ^c   Gilks, Blake ^d   Longacre, Teri ^e   Soslow, Robert A ^f   Oliva, Esther ^g  

^a NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d VANCOUVER GENERAL HOSPITAL   (Canada)

^e STANFORD UNIVERSITY   (United States)

^f MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

leiomyosarcoma; tumor cell necrosis; uterus

Indexed keywords

ARTICLE; FEMALE; HUMAN; LEIOMYOSARCOMA; NECROSIS; OBSERVER VARIATION; PATHOLOGY; UTERUS CANCER;

FEMALE; HUMANS; LEIOMYOSARCOMA; NECROSIS; OBSERVER VARIATION; UTERINE NEOPLASMS;

EID: 84876678109     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3182851162     Document Type: Article

References (55)

1. Hendrickson MR, Tavassoli F, Kempson RL, et al. Mesenchymal tumours and related lesions. In: Tavassoli F, Devilee P, eds. World Health Organization Classification of Tumours Pathology and Genetics of Tumors of Breast and Female Genital Organs. Lyons: IARC; 2003:233-244.
2. Bell SW, Kempson RL, Hendrickson MR. Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases. Am J Surg Pathol. 1994;18:535-558.
3. Jones MW, Norris HJ. Clinicopathologic study of 28 uterine leiomyosarcomas with metastasis. Int J Gynecol Pathol. 1995; 14:243-249.
4. Siegel S, Castellan NJ. Nonparametric Statistics for the Behavioral Sciences (1988) International Edition. New York: McGraw-Hill Book Co.; 1988:284-291.
5. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159-174.
6. Torpin R, Pund E, Peebles WJ. The aetiologic and pathologic factors in a series of 1741 fibromyomas of the uterus. Am J Obstet Gynecol. 1992;44:569-574.
7. Tiltman AJ. Leiomyomas of the uterine cervix: a study of frequency. Int J Gynecol Pathol. 1998;17:231-234.
8. Wilkinson N, Rollason TP. Recent advances in the pathology of smooth muscle tumours of the uterus. Histopathology. 2001;39: 331-341.
9. Yanai H, Wani Y, Notohara K, et al. Uterine leiomyosarcoma arising in leiomyoma: clinicopathological study of four cases and literature review. Pathol Int. 2010;60:506-509.
10. Mittal KR, Chen F, Wei JJ, et al. Molecular and immunohisto-chemical evidence for the origin of uterine leiomyosarcomas from associated leiomyoma and symplastic leiomyoma-like areas. Mod Pathol. 2009;22:1303-1311.
11. Lindberg MR, Fisher C, Thway K, et al. Leiomyosarcoma of the urinary bladder: a clinicopathological study of 34 cases. J Clin Pathol. 2010;63:708-713.
12. Weiss SW. Smooth muscle tumors of soft tissue. Adv Anat Pathol. 2002;9:351-359.
13. Farshid G, Pradhan M, Goldblum J, et al. Leiomyosarcoma of somatic soft tissues: a tumor of vascular origin with multivariate analysis of outcome in 42 cases. Am J Surg Pathol. 2002;26:14-24.
14. Miyajima K, Oda Y, Oshiro Y, et al. Clinicopathological prognostic factors in soft tissue leiomyosarcoma: a multivariate analysis. Histopathology. 2002;40:353-359.
15. Tsujimoto M, Aozasa K, Ueda T, et al. Multivariate analysis for histologic prognostic factors in soft tissue sarcomas. Cancer. 1988; 62:994-998.
16. Hashimoto H, Daimaru Y, Takeshita S, et al. Prognostic significance of histologic parameters of soft tissue sarcomas. Cancer. 1992;70:2816-2822.
17. O'Connor DM, Norris HJ. Mitotically active leiomyomas of the uterus. Hum Pathol. 1990;21:223-227.
18. Perrone T, Dehner LP. Prognostically favorable "mitotically active" smooth-muscle tumors of the uterus. A clinicopathologic study of ten cases. Am J Surg Pathol. 1988;12:1-8.
19. Carvalho JC, Thomas DG, Lucas DR. Cluster analysis of immunohistochemical markers in leiomyosarcoma delineates specific anatomic and gender subgroups. Cancer. 2009;115: 4186-4195.
20. Hendrickson MR, Kempson RL. A diagnostic approach to smooth muscle tumours of the uterus. Curr Diagn Pathol. 2000;6:21-30.
21. Atkins K, Bell SW, Kempson RL. Myxoid smooth muscle tumors of the uterus. Mod Pathol. 2001;14:132A.
22. Toledo G, Oliva E. Smooth muscle tumors of the uterus: a practical approach. Arch Pathol Lab Med. 2008;132:595-605.
23. Donhuijsen K, Schmidt U, Hirche H, et al. Changes in mitotic rate and cell cycle fractions caused by delayed fixation. Hum Pathol. 1990;21:709-714.
24. Tapia C, Kutzner H, Mentzel T, et al. Two mitosis-specific antibodies, MPM-2 and phospho-histone H3 (Ser28), allow rapid and precise determination of mitotic activity. Am J Surg Pathol. 2006;30:83-89.
25. Gal R, Rath-Wolfson L, Rosenblatt Y, et al. An improved technique for mitosis counting. Int J Surg Pathol. 2005;13:161-165.
26. Evason KJ, Rabban JT. The mitosis marker anti-phosphohistoneH3 (PHH3) distinguishes bizarre leiomyoma from leiomyosarcoma and predicts behavior in uterine smooth muscle tumors. Mod Pathol. 2009;22:213A.
27. Toledo G, Growdon WB, Palmeri MLD, et al. Utility of the mitosis marker anti-phosphohistone H3 (PHH3) in precise and rapid evaluation of mitotic Index in leiomyomas with bizarre nuclei. Mod Pathol. 2008;21:226A-227A.
28. Veras E, Malpica A, Deavers MT, et al. Mitosis-specific marker phospho-histone H3 in the assessment of mitotic index in uterine smooth muscle tumors: a pilot study. Int J Gynecol Pathol. 2009;28:316-321.
29. Oliva ECP, Young RH. Mesenchymal tumors of the uterus: selected topics emphasizing potential pitfalls. Curr Diagn Pathol. 2002;8: 268-282.
30. Billings SD, Folpe AL, Weiss SW. Do leiomyomas of deep soft tissue exist? an analysis of highly differentiated smooth muscle tumors of deep soft tissue supporting two distinct subtypes. Am J Surg Pathol. 2001;25:1134-1142.
31. Miettinen M, Fetsch JF. Evaluation of biological potential of smooth muscle tumours. Histopathology. 2006;48:97-105.
32. Prayson RA, Hart WR. Mitotically active leiomyomas of the uterus. Am J Clin Pathol. 1992;97:14-20.
33. Clement PB. The pathology of uterine smooth muscle tumors and mixed endometrial stromal-smooth muscle tumors: a selective review with emphasis on recent advances. Int J Gynecol Pathol. 2000;19:39-55.
34. Amant F, Moerman P, Vergote I. Report of an unusual problematic uterine smooth muscle neoplasm, emphasizing the prognostic importance of coagulative tumor cell necrosis. Int J Gynecol Cancer. 2005;15:1210-1212.
35. Clement PB, Young RH, Scully RE. Nontrophoblastic pathology of the female genital tract and peritoneum associated with pregnancy. Semin Diagn Pathol. 1989;6:372-406.
36. Myles JL, Hart WR. Apoplectic leiomyomas of the uterus. A clinicopathologic study of five distinctive hemorrhagic leiomyomas associated with oral contraceptive usage. Am J Surg Pathol. 1985;9:798-805.
37. Norris HJ, Hilliard GD, Irey NS. Hemorrhagic cellular leiomyomas ("apoplectic leiomyoma") of the uterus associated with pregnancy and oral contraceptives. Int J Gynecol Pathol. 1988; 7:212-224.
38. Wang W, Soslow RA, Zannoni G, et al. The utility of tumor cell necrosis in the diagnosis of primary leiomyosarcoma of the uterus: an analysis of 77 cases. Mod Pathol. 2006;18:201A.
39. Mulayim N, Gucer F. Borderline smooth muscle tumors of the uterus. Obstet Gynecol Clin North Am. 2006;33:171-181.
40. Ip PP, Cheung AN, Clement PB. Uterine smooth muscle tumors of uncertain malignant potential (STUMP): a clinicopathologic analysis of 16 cases. Am J Surg Pathol. 2009;33:992-1005.
41. Atkins KA, Arronte N, Darus CJ, et al. The use of p16 in enhancing the histologic classification of uterine smooth muscle tumors. Am J Surg Pathol. 2008;32:98-102.
42. Peters WA III, Howard DR, Andersen WA, et al. Uterine smooth-muscle tumors of uncertain malignant potential. Obstet Gynecol. 1994;83:1015-1020.
43. Evans HL, Chawla SP, Simpson C, et al. Smooth muscle neoplasms of the uterus other than ordinary leiomyoma. A study of 46 cases, with emphasis on diagnostic criteria and prognostic factors. Cancer. 1988;62:2239-2247.
44. Larson B, Silfversward C, Nilsson B, et al. Prognostic factors in uterine leiomyosarcoma. A clinical and histopathological study of 143 cases. The radiumhemmet series 1936-1981. Acta Oncol. 1990;29:185-191.
45. Pelmus M, Penault-Llorca F, Guillou L, et al. Prognostic factors in early-stage leiomyosarcoma of the uterus. Int J Gynecol Cancer. 2009;19:385-390.
46. Abeler VM, Royne O, Thoresen S, et al. Uterine sarcomas in norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients. Histopatho-logy. 2009;54:355-364.
47. Akhan SE, Yavuz E, Tecer A, et al. The expression of Ki-67, p53, estrogen and progesterone receptors affecting survival in uterine leiomyosarcomas. A clinicopathologic study. Gynecol Oncol. 2005; 99:36-42.
48. Wang WL, Soslow R, Hensley M, et al. Histopathologic prognostic factors in stage I leiomyosarcoma of the uterus: a detailed analysis of 27 cases. Am J Surg Pathol. 2011;35:522-529.
49. Veras E, Zivanovic O, Jacks L, et al. "Low-grade leiomyosarcoma" and late-recurring smooth muscle tumors of the uterus: a hetero-genous collection of frequently misdiagnosed tumors associated with an overall favorable prognosis relative to conventional uterine leiomyosarcomas. Am J Surg Pathol. 2011;35:1626-1637.
50. Dinh TA, Oliva EA, Fuller AF Jr., et al. The treatment of uterine leiomyosarcoma. results from a 10-year experience (1990-1999) at the massachusetts general hospital. Gynecol Oncol. 2004;92:648-652.
51. Giuntoli RL III, Metzinger DS, DiMarco CS, et al. Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy. Gynecol Oncol. 2003;89:460-469.
52. Major FJ, Blessing JA, Silverberg SG, et al. Prognostic factors in early-stage uterine sarcoma. A gynecologic oncology group study. Cancer. 1993;71:1702-1709.
53. Mayerhofer K, Obermair A, Windbichler G, et al. Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases. Gynecol Oncol. 1999;74:196-201.
54. Shapiro A, Ferenczy A, Turcotte R, et al. Uterine smooth-muscle tumor of uncertain malignant potential metastasizing to the humerus as a high-grade leiomyosarcoma. Gynecol Oncol. 2004; 94:818-820.
55. Berretta R, Rolla M, Merisio C, et al. Uterine smooth muscle tumor of uncertain malignant potential: a three-case report. Int J Gynecol Cancer. 2008;18:1121-1126.